Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ANTXANTX
17 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in AN2 THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 697,806 shares of ANTX (AN2 THERAPEUTICS INC), worth $3.4M as of 2026-Q2. The position was increased (+143.5% shares). ANTX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$3.4M

Current Shares

697,806

Total Value Change

+$2.8M

Total Shares Change

+621,339

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
697,806
+143.5%
$3.4M0.0%$4.84
43
2026-Q1
Increased
286,547
+13.8%
$980,8380.0%$1.06
28
2025-Q4
Increased
251,875
+1.0%
$287,1990.0%$1.08
16
2025-Q3
Unchanged
249,351
0.0%
$316,7470.0%$1.28
0
2025-Q2
Decreased
249,351
-1.8%
$264,3670.0%$1.08
0
2025-Q1
Increased
253,923
+11.5%
$345,4210.0%$1.39
18
2024-Q4
Increased
227,796
+3.5%
$314,4450.0%$1.41
17
2024-Q3
Increased
220,162
+21.7%
$235,6270.0%$1.06
19
2024-Q2
Increased
180,923
+0.9%
$389,0980.0%$2.15
16
2024-Q1
Increased
179,370
+0.4%
$583,1190.0%$3.25
24
2023-Q4
Increased
178,623
+99.2%
$3.7M0.0%$20.49
43
2023-Q3
Increased
89,691
+69.3%
$1.4M0.0%$16.08
38
2023-Q2
Decreased
52,962
-63.5%
$450,1770.0%$8.40
0
2023-Q1
Increased
144,947
+17.8%
$1.4M0.0%$9.63
30
2022-Q4
Increased
123,085
+47.8%
$1.2M0.0%$9.53
35
2022-Q3
Increased
83,291
+8.9%
$1.4M0.0%$15.32
28
2022-Q2
New
76,467
-
$592,0000.0%$7.91
34

Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used